Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin, duloxetine, and celecoxib after total knee arthroplasty for osteoarthritis
ChiCTR2200056163Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pregabalin, duloxetine and celecoxib in osteoarthritis (OA) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Visual analog pain score and Pressure pain threshold of the operated knee. Started Feb 2022; status: recruiting.
02
Drugs
pregabalinduloxetinecelecoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200056163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056163.